A Study of E7389 Liposomal Formulation (E7389-LF) Plus Nivolumab in Participants With Solid Tumor
A Study of E7389 Liposomal Formulation (E7389-LF) Plus Nivolumab in Participants With Solid Tumor
Active, not recruiting · NCT04078295 · Registry updated 2026-02-10Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| A Study of E7389 Liposomal Formulation (E7389-LF) Plus Nivolumab in Participants With Solid Tumor | neoplasm | Active, not recruiting | Phase 1 / Phase 2 | 2026-02-10 | NCT04078295 |
2 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Eisai Co., Ltd. | 15 |
| Ono Pharmaceutical Co., Ltd. | 47 |
19 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Eisai Trail Site #16 | Sunto-g | Japan | 1 |
| Eisai Trial Site #1 | Chuo Ku | Japan | 2 |
| Eisai Trial Site #10 | Koto-Ku | Japan | 1 |
| Eisai Trial Site #11 | Akashi | Japan | 1 |
| Eisai Trial Site #12 | Kōtoku | Japan | 1 |
| Eisai Trial Site #13 | Nagoya | Japan | 1 |
| Eisai Trial Site #14 | Matsuya | Japan | 1 |
| Eisai Trial Site #15 | Yokohama | Japan | 1 |
| Eisai Trial Site #17 | Suita | Japan | 1 |
| Eisai Trial Site #18 | Kashiwa | Japan | 1 |
| Eisai Trial Site #19 | Kitaadachi-gun | Japan | 1 |
| Eisai Trial Site #2 | Kashiwa | Japan | 2 |
| Eisai Trial Site #3 | Sendai | Japan | 1 |
| Eisai Trial Site #4 | Kurume | Japan | 2 |
| Eisai Trial Site #5 | Osakasa | Japan | 1 |
| Eisai Trial Site #6 | Chuo Ku | Japan | 1 |
| Eisai Trial Site #7 | Sakai C | Japan | 1 |
| Eisai Trial Site #8 | Chuo Ku | Japan | 1 |
| Eisai Trial Site #9 | Wakayama | Japan | 1 |